Advanced search
Publication Cover
OncoTargets and Therapy Volume 6, 2013 - Issue
Submit an article Journal homepage
60
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials

Yiliang Zhang1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, People’s Republic of China
,
Yihua Sun1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, People’s Republic of China
,
Lei Wang1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, People’s Republic of China
,
Ting Ye1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, People’s Republic of China
,
Yunjian Pan1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, People’s Republic of China
,
Haichuan Hu1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, People’s Republic of China
,
Yongfu Yu2 Department of Biostatistics, School of Public Health, Fudan University, People’s Republic of China
,
Naiqing Zhao2 Department of Biostatistics, School of Public Health, Fudan University, People’s Republic of China
,
Yanyan Song3 Department of Pharmacology and Biostatistics, Institute of Medical Science, Shanghai Jiaotong University School of Medicine, People’s Republic of China
,
David Garfield4 ProMed Cancer Centers, Shanghai, People’s Republic of China
&
Haiquan Chen1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 1771-1777 | Published online: 29 Nov 2013

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.